A1C Level and Future Risk of Diabetes: A Systematic Review
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
We examined ranges of A1C useful for identifying persons at high risk for diabetes prior to preventive intervention by conducting a systematic review. From 16 included studies, we found that annualized diabetes incidence ranged from 0.1% at A1C <5.0% to 54.1% at A1C >or=6.1%. Findings from 7 studies that examined incident diabetes across a broad range of A1C categories showed 1) risk of incident diabetes increased steeply with A1C across the range of 5.0 to 6.5%; 2) the A1C range of 6.0 to 6.5% was associated with a highly increased risk of incident diabetes, 25 to 50% incidence over 5 years; 3) the A1C range of 5.5 to 6.0% was associated with a moderately increased relative risk, 9 to 25% incidence over 5 years; and 4) the A1C range of 5.0 to 5.5% was associated with an increased incidence relative to those with A1C <5%, but the absolute incidence of diabetes was less than 9% over 5 years. Our systematic review demonstrated that A1C values between 5.5 and 6.5% were associated with a substantially increased risk for developing diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As with the glucose measures, several prospective studies that used A1C to predict the progression to diabetes as de fi ned by A1C criteria demonstrated a strong, continuous association between A1C and subsequent diabetes.”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Those with an A1C range of 6.0 -6.5% (42 -48 mmol/mol) had a 5-year risk of developing diabetes between 25% and 50% and a relative risk 20 times higher than that with A1C of 5.0% (31 mmol/mol) (81).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies suggest that the risk of diabetes development on the basis of FPG and 2-h postload glucose is broadly similar to that posed by A1c.14,18”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Similar to glucose measurements, the continuum of risk is continuous: as A1C rises, the diabetes risk rises disproportionately (81).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“In a systematic review of 44,203 individuals from 16 cohort studies with a follow-up interval averaging 5.6 years (range 2.8 -12 years), those with A1C between 5.5% and 6.0% (between 37 and 42 mmol/mol) had a substantially increased risk of diabetes (5-year incidence from 9% to 25%).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Breslow, N., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,333
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812
Gerstein, H. C., Santaguida, P., Raina, P., Morrison, K. M., Balion, C., Hunt, D., Yazdi, H., & Booker, L. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.05.004 · Cited by 575 · cited 1×
“The progression of risk of diabetes with A1C is similar in magnitude and shape as previously described for fasting plasma glucose and 2-h glucose and suggests that A1C may have a similar application as an indicator of future risk (27).”
BackgroundRelationship between glycated haemoglobin levels and mean glucose levels over time
Nathan, D. M., Turgeon, H., & Regan, S. (2007) · Diabetologia · doi:10.1007/s00125-007-0803-0 · Cited by 517 · cited 1×
“A1C better reflects long-term glycemic exposure than current diagnostic tests based on point-intime measures of fasting and postload blood glucose (4,5) and has improved test-retest reliability (6).”
BackgroundShort-term variability in measures of glycemia and implications for the classification of diabetes
Selvin, E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1545 · Cited by 402 · cited 1×
“A1C better reflects long-term glycemic exposure than current diagnostic tests based on point-intime measures of fasting and postload blood glucose (4,5) and has improved test-retest reliability (6).”
Background
Research works printed but not linked: 1
- Clarke, 2001, Cochrane Reviewers Handbook
Cited by
Items 201–300 of 422
Park, J., Zhang, P., Shao, H., Laxy, M., & Imperatore, G. (2022) · Diabetic Medicine · doi:10.1111/dme.14847 · Cited by 10
Self-citationPerreault, L., Færch, K., & Gregg, E. W. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0899-7 · Cited by 12
Self-citationDolscheid‐Pommerich, R., Kirchner, S., Weigel, C., Eichhorn, L., Conrad, R., Stoffel‐Wagner, B., & Zur, B. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.01.034 · Cited by 15
“0% (37 and 42 mmol/ mol) had an up to 25% higher risk of developing diabetes mellitus within the next five years [32].”
BackgroundBrateanu, A., Barwacz, T., Kou, L., Wang, S., Misra‐Hebert, A. D., Hu, B., Deshpande, A., Kobaivanova, N., & Rothberg, M. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187695 · Cited by 9
Salivary Metabolomics of Well and Poorly Controlled Type 1 and Type 2 Diabetes
Bencharit, S., Carlson, J., Byrd, W. C., Howard-Williams, E. L., Seagroves, J. T., McRitchie, S., Buse, J. B., & Sumner, S. (2022) · International Journal of Dentistry · doi:10.1155/2022/7544864 · Cited by 10
“5 or lower represents a low risk or well-controlled diabetes [35], whereas A1C> 9 represents poorly controlled diabetes [36].”
Alemi, S., Nakamura, K., Arab, A. S., Mashal, M. O., Tashiro, Y., Seino, K., & Hemat, S. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001676 · Cited by 9
Progression from Prediabetes to Diabetes in a Diverse U.S. Population: A Machine Learning Model
Aoki, J., Khalid, O. M., Kaya, C., Nagymányoki, Z., Hussong, J. W., & Salama, M. E. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0052 · Cited by 12
“19 Owing to its detrimental impact, valuable insight is gained by the ability to accurately identify which patients are most at risk for progression from prediabetes to diabetes.”
InfluentialPreventing Diabetes in the Workplace: Effects of Coaching and Monetary Incentives
Raymond, L. W., Roy, D. M., Mullinax, S. L., Yanni, A., Pentek, K. C., & Isaacs, S. E. (2019) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001611 · Cited by 9
“Of the 24 Group A WPP who progressed from prediabetes to DM over 5 years, their number was only one-third of that expected from the meta-analysis of Zhang et al.24 The great majority of Americans with prediabetes—up to 90% of 84 million—are unaware of this condition.3,30 Its identification in the workplace could preve…”
BackgroundResultInfluentialShriqui, V. K., O'Campo, P. J., Misir, V., Schäfer, P., Morinis, J., Vance, M. R., Schetter, C. D., Raju, T. N. K., Hillemeier, M. M., Lanzi, R. G., et al. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-1275-x · Cited by 10
“6, [33] average systolic blood pressure (SBP) ≥135, average diastolic blood pressure (DBP) ≥85, [34, 35] and HDL cholesterol ≤40 [36, 37].”
BackgroundBharmal, S. H., Kimita, W., Ko, J., & Petrov, M. S. (2021) · Endocrine Connections · doi:10.1530/ec-21-0229 · Cited by 9
“It is estimated that up to 75% of individuals with prediabetes may progress to diabetes mellitus (10, 11).”
BackgroundPrediabetes and coronary artery disease: Outcome after revascularization procedures
Recalde, J. F. C., Arroyo, J. R. R., & García-Blanco, F. R. (2016) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2016.02.010 · Cited by 13
High HbA1c level is correlated with blood-brain barrier disruption in syphilis patients
Wang, F., Ge, H., Su, X., Wang, R., Zeng, J., & Miao, J. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04031-x · Cited by 10
Park, S., Ballreich, J. M., Ward, T., & Shi, L. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15807 · Cited by 10
“30 The remainder was grouped as prediabetic or NGT stages based on the American Diabetes Association criteria for prediabetes using HbA1c levels 31 (Appendix A4 in Appendix S1).”
Zhang, Y., Liu, S., Cao, B., Xu, J., Jia, W., & Wang, C. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111963 · Cited by 8
1. Detection of diabetes and intermediate hyperglycaemia, and prevention of type 2 diabetes
Colagiuri, S., & Ceriello, A. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112145 · Cited by 14
Mitchell, A. J., Vancampfort, D., Manu, P., Correll, C. U., Wampers, M., van Winkel, R., Yu, W., & Binder, M. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210674 · Cited by 12
“5% (42 mmol/mol—48 mmol/mol) had a 5-year risk of diabetes of 25% to 50% [6].”
BackgroundWang, S., Niu, J., Zhao, Z., Xu, M., Lu, J., Li, M., Wang, T., Chen, Y., Wang, S., Dai, M., et al. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13028 · Cited by 8
“This might be explained by the continuum of risk for the development of diabetes based on HbA1c levels as with measures of glucose.(20,36) In addition, the uncertainty of guidelines surrounding values for prediabetes might also present difficulties.”
Sosibo, A. M., Mzimela, N. C., Ngubane, P. S., & Khathi, A. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.10.004 · Cited by 14
Zhao, M., Yang, S., Su, X., Hung, T.-C., Liu, Y., & Zheng, W. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.938149 · Cited by 8
Engaging Payors and Primary Care Physicians Together in Improving Diabetes Prevention
Tseng, E., Meza, K., Marsteller, J. A., Clark, J. M., Maruthur, N. M., & Smith, K. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07788-8 · Cited by 8
“Prediabetes affects 1 in 3 US adults(1) and increases the risk of type 2 diabetes with a 5-year risk of up to 50%.(2) Fortunately, type 2 diabetes can be prevented or delayed through intensive lifestyle programs like the Diabetes Prevention Program (DPP).”
BackgroundCalabria, E., Muollo, V., Cavedon, V., Capovin, T., Saccenti, L., Passarotti, F., Ghiotto, L., Milanese, C., Gelati, M., Rudi, D., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11010121 · Cited by 10
“The literature is richer in studies on diabetic patients than on pre-diabetic subjects, but it is becoming evident that there is a relation between the continual increase in Hb1Ac and a related greater risk of diabetes, and that in the early steps of this increase, the condition can still be reversed with lifestyle in…”
BackgroundKutob, R. M., Siwik, V. P., Aickin, M. G., & Ritenbaugh, C. (2014) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721714520722 · Cited by 9
“Compared with those with normal hemoglobin A1C values, those with prediabetes may have a 20 times higher 5-year risk of developing diabetes than those with normal hemoglobin A1C values.(2) Prediabetes is also one of several indicators of metabolic syndrome, along with hypertension, dyslipidemia, and increased adiposit…”
BackgroundLee, J. A., & Laurson, K. R. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.11.009 · Cited by 10
Prediabetes—A Risk Factor Twice Removed
Lam, K., & Lee, S. J. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.8773 · Cited by 7
Lower-Intensity Interventions for Prediabetes: A Systematic Review
Tseng, E., Lam, K. Y., Meza, K., O’Brien, M. J., & Maruthur, N. M. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.05.012 · Cited by 12
Remote HbA1c testing via microsampling: fit for purpose?
Verougstraete, N., Stove, V. V., & Stove, C. P. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0228 · Cited by 7
Merolla, A., LORENZO, R. D., Ferrannini, G., Renzi, C., Ulivi, F., Bazzigaluppi, E., Lampasona, V., & Bosi, E. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078983 · Cited by 8
Taylor, B. E., Howell, S. J., Lee, C. A., Taylor, Z. R. R., Barber, K. G., & Taylor, P. R. (2025) · Antioxidants · doi:10.3390/antiox14020205 · Cited by 10
“In both humans and mice, non-diabetics have HbA 1C scores below 5.7%, and diabetics have HbA 1C scores above 6.5% [26].”
InfluentialValidation of a screening tool for identifying Brazilians with impaired glucose tolerance
de Moura, B. P., Amorim, P. R. D. S., Franceschini, S. D. C. C., Reis, J. S., & Marins, J. C. B. (2012) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-012-0074-2 · Cited by 9
“0 % was associated with a highly increased risk of incident diabetes [17].”
BackgroundMa, C.-T., Wu, Y., Huang, H. H., Kang, P., Hsiao, K. Y., Lo, D. Y., & Kuo, S. M. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00731g · Cited by 7
Prediabetes awareness among Southeastern European physicians
Kokić, V., Kokić, S., Krnić, M., Petrić, M., Liberati, A. M., Šimac, P., Milenković, T., Čapkun, V., Rahelić, D., & Blaslov, K. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12740 · Cited by 8
Alemi, S., Nakamura, K., Arab, A. S., Mashal, M. O., Tashiro, Y., Seino, K., & Hemat, S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18115729 · Cited by 13
“The cut-off value for HbA1c was determined based on a study investigating the threshold of HbA1c for screening of diabetes [20] and a systematic review of HbA1c level and risk of diabetes [21].”
MethodYamamoto‐Kataoka, S., Shimizu, S., Yamazaki, H., Murakami, K., Nishizaki, D., Fukuhara, S., Inagaki, N., & Yamamoto, Y. (2021) · Medicine · doi:10.1097/md.0000000000026311 · Cited by 8
“5%),([19]) and blood glucose level into 2 categories (<200 and ≥200mg/dL).”
BackgroundRondanelli, M., Barrile, G. C., Cavioni, A., Donati, P., Genovese, E., Mansueto, F., Mazzola, G., Patelli, Z., Pirola, M., Razza, C., et al. (2023) · Nutrients · doi:10.3390/nu15234943 · Cited by 10
Enhancing Early Diagnosis: Machine Learning Applications in Diabetes Prediction
Kalla, D., Smith, N., Samaah, F., & Polimetla, K. (2022) · Journal of Artificial Intelligence & Cloud Computing · doi:10.47363/jaicc/2022(1)191 · Cited by 17
Bancks, M. P., Odegaard, A., Koh, W., Yuan, J., Gross, M. D., & Pereira, M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119884 · Cited by 8
Fu, S. N., Luk, W., Wong, C. K. H., & Cheung, K. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12120 · Cited by 9
Vaghani, H., Mehta, R., Desai, K., Duseja, S., & Mehta, T. (2016) · Advances in Human Biology · doi:10.4103/2321-8568.190313 · Cited by 7
Krabbe, C., Schipf, S., Ittermann, T., Dörr, M., Nauck, M. A., Chenot, J., Markus, M. R. P., & Völzke, H. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.07.016 · Cited by 8
Définition, classification et diagnostic du diabète, du prédiabète et du syndrome métabolique
Goldenberg, R., & Punthakee, Z. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.031 · Cited by 22
Classification and identification of risk factors for type 2 diabetes
Tang, S., Zhao, X., An, X., Sun, W., Kang, X., Sun, Y., Jiang, L., Gao, Q., Li, Z., Ji, H., et al. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i2.100371 · Cited by 10
Washirasaksiri, C., Borrisut, N., Lapinee, V., Sitasuwan, T., Tinmanee, R., Kositamongkol, C., Ariyakunaphan, P., Tangjittipokin, W., Plengvidhya, N., & Srivanichakorn, W. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004803 · Cited by 8
“24 43–45 Our analysis revealed differing type 2 diabetes incidences among the clusters.”
Bartáková, V., Chalásová, K., Pácal, L., Ťápalová, V., Máchal, J., Janků, P., & Kaňková, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051260 · Cited by 6
“GDM is traditionally defined as any degree of glucose intolerance first recognised during pregnancy, regardless of the degree of hyperglycaemia [1].”
BackgroundПетровна, З. А., Gemoets, D. E., Kaminsky, L. S., & Gosmanov, A. R. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002554 · Cited by 6
Genome-Wide Association Study on Longitudinal Change in Fasting Plasma Glucose in Korean Population
Jin, H., Kwak, S. H., Yoon, J. W., Lee, S., Park, K. S., Won, S., & Cho, N. H. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0375 · Cited by 7
“This is also suggested by the fact that only about 25% of prediabetes subjects progress to T2DM in 5 years of follow-up [5].”
Aung, N. L. (2023) · Clinical Diabetes · doi:10.2337/cd23-0084 · Cited by 7
Anderson, P., Grills, N., Singh, R. P., Singh, R., Evans, R. G., Sengupta, P., & Thrift, A. G. (2019) · BMC Public Health · doi:10.1186/s12889-019-7184-4 · Cited by 6
Velez, M., Chasan‐Taber, L., Goldwater, E., & VanKim, N. A. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3538746 · Cited by 7
“Indeed, recent studies have found that individuals who have prediabetes have a 20 times higher risk of progressing to type 2 diabetes within five years of diagnosis as compared to those with normal glucose levels [3].”
BackgroundSiddiqui, S., Zainal, H., Harun, S. N., & Ghadzi, S. M. S. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.06.022 · Cited by 8
Sun, Y., Zhang, W., Lu, L., Zhao, D., Wang, S., Pan, Y., & Li, C. (2024) · Journal of Dentistry · doi:10.1016/j.jdent.2024.104974 · Cited by 6
Ziyab, A. H., Mohammad, A., Almousa, Z., & Mohammad, T. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00311-4 · Cited by 5
“%) to diabetes to be 25% to 50% [4].”
Shapiro, A. J., Holden, E. C., McGovern, P. G., Alderson, D., & Morelli, S. S. (2019) · Clinical Medicine Insights Reproductive Health · doi:10.1177/1179558119831280 · Cited by 5
Fornari, E., Barbetti, F., Iafusco, D., Lombardo, F., GIUDICE, E. M. D., Rabbone, I., & Mozzillo, E. (2021) · Minerva Pediatrics · doi:10.23736/s2724-5276.21.06530-7 · Cited by 7
Association between prediabetes definition and progression to diabetes: The REDIA follow-up study
Anthony, N., Lenclume, V., Fianu, A., Moullec, N. L., Debussche, X., Gérardin, P., Marimoutou, C., & Nobécourt, E. (2021) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2021.100024 · Cited by 5
Influence of metabolic disorders on the development of renal pathology
Bashkinov, R. A., Батлук, Т. И., Мельников, Е. С., Trubnikova, M. A., & Arutyunov, A. G. (2022) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2022-3-2-7-18 · Cited by 5
Mott, J., Dolan, J. K., Gilor, C., & Gilor, S. (2023) · Veterinary Clinical Pathology · doi:10.1111/vcp.13257 · Cited by 7
HbA1C and diabetes – an overview
Pathmanathan, S., & Somasundaram, N. P. (2014) · Sri Lanka Journal of Diabetes Endocrinology and Metabolism · doi:10.4038/sjdem.v3i2.6379 · Cited by 5
“5% will capture a large portion of people at high risk, and if interventions can be employed to this target population, it may bring about significant absolute risk reduction (21,22).”
BackgroundVerier‐Mine, O. (2010) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/s0368-2315(10)70056-9 · Cited by 8
“[102] Zhang EW, Gregg EW, Williamson DF, Barker LE, Thomas W, McKeven Bullard K et al.”
BackgroundVillanueva-Sosa, L. G., Cordero-Franco, H. F., & Salinas-Martínez, A. M. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0040 · Cited by 6
“In 11–13 It is notable that abnormal HbA1c levels, even in a nondiabetic population, increase one’s cardiovascular risk.”
Malik, A. A. (2015) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2015.02.00026 · Cited by 5
Srivanichakorn, W., Godsland, I. F., Thomson, H., Misra, S., Phisalprapa, P., Charatcharoenwitthaya, P., Pramyothin, P., Washirasaksiri, C., Snehalatha, C., Ramachandran, A., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.10.017 · Cited by 6
Perioperative hyperglycaemia in elective arthroplasties. Should we do better?
Ylikoski, M., Jokinen, J. J., Lahtela, J. T., Kauppi, M. J., Huhtala, H., Immonen, H., & Tiihonen, R. (2020) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13666 · Cited by 5
Lin, R., Chien, K., Tsai, M.-C., Wang, Y., & Hsu, L. (2023) · Journal of Nutritional Science · doi:10.1017/jns.2023.8 · Cited by 6
“In PLS, we used baseline fasting plasma glucose and haemoglobin A1c as response variables((36,37)) to derive factors (dietary patterns) that maximally explained the covariance of the response variables and food groups.”
MethodSpeaking to Patients About Diabetes Risk: Is Terminology Important?
Tarasova, V. D., Caballero, J. A., Turner, P., & Inzucchi, S. E. (2014) · Clinical Diabetes · doi:10.2337/diaclin.32.2.90 · Cited by 5
Petry, N., Rohner, F., Phall, M. C., Jallow, B., Ceesay, A. A., Sawo, Y., Darboe, M. K., Barrow, S., Sarr, A., Ceesay, P. O., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91592-7 · Cited by 6
Предіабет і метаболічний синдром. Характеристика і маркери
SOKOLOVA, L. K., Pushkarev, V. M., & Tronko, M. D. (2021) · Endokrynologia · doi:10.31793/1680-1466.2021.26-2.179 · Cited by 8
Kurniawati, D. M., & Isnawati, M. (2016) · Jurnal Gizi Indonesia (The Indonesian Journal of Nutrition) · doi:10.14710/jgi.4.2.125-130 · Cited by 6
Okere, A. N., Li, T. Y., Theran, C. A., Nyasani, E., & Ali, A. A. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109824 · Cited by 9
Regidor, E., Soriano, L. C., Ruíz, A., Goday, A., Carabantes-Alarcón, D., Díez‐Espino, J., Artola, S., Franch‐Nadal, J., & for the PREDAPS Study Group (2021) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2021.1958497 · Cited by 4
“the prognosis for prediabetes in different studies [27]”
BackgroundLieb, W., de Oliveira, C. M., Pan, S., Echouffo-Tcheugui, J. B., Weber, K. S., Vasan, R. S., & Xanthakis, V. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002581 · Cited by 8
“25 Association of glycemic markers with incident type 2 diabetes Glycemic markers such as fasting glucose, 27 2h-glucose 28 and HbA 1C , 29 and different insulin measures (including concentrations of insulin and proinsulin), 30 have been related to the incidence of diabetes.”
Mostafa, S. A., Khunti, K., Srinivasan, B. T., Webb, D. R., & Davies, M. J. (2011) · Diabetes Management · doi:10.2217/dmt.10.11 · Cited by 6
Arai, N. I. C. (2014) · Epidemiology Open Access · doi:10.4172/2161-1165.1000157 · Cited by 4
Wang, D., Qiang, D., Xu, W., Wang, J., Liu, J., Qin, Y., Zhang, Y., Liu, Q., & Xiang, Q. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14557 · Cited by 8
Diagnostic Criteria and Classification of Diabetes
Gospin, R., Leu, J. P., & Zonszein, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_7-2 · Cited by 6
Xue, M., Dutton, H., & Arnaout, A. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.04.014 · Cited by 4
Alhassan, Z., Budgen, D., Alshammari, R., & Moubayed, N. A. (2020) · JMIR Medical Informatics · doi:10.2196/18963 · Cited by 6
Sohouli, M. H., Tavakoli, S., Reis, M. G., Hekmatdoost, A., & Guimarães, N. S. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00812-0 · Cited by 4
Cao, C., Zan, Y., Han, Y. Y., Hu, H., Long, J., & Wang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-05786-4 · Cited by 4
“%) exhibiting a significantly higher risk of developing diabetes compared to those with lower HbA1c levels 26 .”
D’Souza, N. C., ALEALI, N., Shakeri, D., ATHERLEY, S. C., Hoffman, E. G., KARIMI-CHAHARTASH, S., JAVANBAKHSH, S., Chan, O. T. M., Liggins, R., & Riddell, M. C. (2026) · Endocrinology · doi:10.1210/endocr/bqaf192 · Cited by 4
Crider, K. S., Adisa, O., Pfeiffer, C., Wang, A., Zhou, Y., Yeung, L. F., Bullard, K., Qi, Y., Rose, C., Fazili, Z., et al. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101193 · Cited by 3
Self-citationTang, Y., Jia, L., Zhou, J., Dou, J., Qian, J., Yi, X., & Soh, K. L. (2026) · Medicine · doi:10.1097/md.0000000000047522 · Cited by 4
Challenge of diabetes mellitus and researchers’ contributions to its control
Odularu, A. T., & Ajibade, P. A. (2021) · Open Chemistry · doi:10.1515/chem-2020-0153 · Cited by 5
“[164] Zhang X, Gregg EW, Williamson DF, Barker LE, Thomas W,”
BackgroundMethodPark, H.-W., Her, S., Jung, J., Chun, H., & Chung, W.-S. (2022) · Life · doi:10.3390/life12111945 · Cited by 3
The Effect of Postinduction Blood Glucose on Intraoperative Hypothermia
Shen, Z., Kuroda, K., & Morimatsu, H. (2023) · Medicina · doi:10.3390/medicina59020395 · Cited by 3
“Based on previous studies [21,22], we considered an HbA1c >6.”
MethodHassan, S., Sobers, N., Paul-Charles, J., Herbert, J., Dharamraj, K., Cruz, E., García-Rivera, E. J., Fredericks, L., Desai, M. M., Roy, S., et al. (2021) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2021.100750 · Cited by 3
Quality of Diabetes Care in the USA
Alencherry, B., & Bruemmer, D. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01503-5 · Cited by 4
Clinical Use and Limitation of Hemoglobin A1c Examination
Suastika, K. (2021) · Clinical Diabetology · doi:10.5603/dk.a2021.0045 · Cited by 5
O’Brien, M. J., Vargas, M. C., Lopez, A., Feliciano, Y., Gregory, D. L., Carcamo, P., Mohr, L., Mohanty, N., Padilla, R., Ackermann, R. T., et al. (2022) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2022.101979 · Cited by 4
Liu, I. H., Uchida, Y., Joo, E., Mano-Usui, F., Okura, M., Chishima, Y., Ikeda, K., & Inagaki, N. (2023) · Japanese Psychological Research · doi:10.1111/jpr.12464 · Cited by 3
Hrubeniuk, T. J., B̀ouchard, D. R., Gurd, B. J., & Sénéchal, M. (2024) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2023-0495 · Cited by 3
Using nephropathy as an outcome to determine the HbA1c diagnostic threshold for type 2 diabetes
Butler, A. E., Hunt, S. C., & Kilpatrick, E. S. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103005 · Cited by 5
Reece, S. W., Parihar, H. S., & Martinez, M. (2018) · Diabetes Spectrum · doi:10.2337/ds17-0002 · Cited by 8
“Risk factors during pregnancy, such as elevated A1C (indicative of hyperglycemia), obesity (indicative of insulin resistance), and gestational weight gain, are associated with adverse maternal and fetal outcomes in patients with GDM (4).”
BackgroundInfluentialSpurr, S., Bally, J. M. G., Mcharo, S. K., & Hyslop, S. (2021) · Journal for Specialists in Pediatric Nursing · doi:10.1111/jspn.12351 · Cited by 6
Fiorentino, T. V., Suraci, E., Vito, F. D., Cimellaro, A., Hribal, M. L., Sciacqua, A., Andreozzi, F., Luzza, F., & Sesti, G. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109094 · Cited by 4
Skelton, J. A., & Cohen, G. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-67293-1.00014-1 · Cited by 3
Gianchandani, R. Y., Saberi, S., Zrull, C. A., Patil, P. V., Jha, L., Kling-Colson, S. C., Gandia, K., DuBois, E. C., Plunkett, C. D., Bodnar, T. W., et al. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0074 · Cited by 3
“It is well known that elevated levels of A1C and FPG confer risks for future type 2 diabetes and cardiovascular events and that these risks are curvilinear.(18) Patients need to be informed of these results to make appropriate lifestyle and medical interventions, especially in this high-risk cardiothoracic surgery pop…”
Shah, A. N., Zargar, S., & D'Souza, C. (2013) · Journal of Social Health and Diabetes · doi:10.4103/2321-0656.115306 · Cited by 3
“5%.[8] For persons with HbA1c between 5.”
Diabetes mellitusun tanı ve izlem kriterleri
Atmaca, A. (2012) · Journal of Experimental and Clinical Medicine · doi:10.5835/jecm.omu.29.s1.002 · Cited by 3
An Introduction to Redox Balance and Lipid Oxidation
Spickett, C. M., & Forman, H. J. (2015) · CRC Press eBooks · doi:10.1201/b18138-6 · Cited by 3
ForgIng New paths in DIabetes PrevenTion (FINDIT): Study Protocol for a Randomized Controlled Trial
Kullgren, J. T., Youles, B., Shetty, S., Richardson, C. R., Fagerlin, A., & Heisler, M. (2017) · Trials · doi:10.1186/s13063-017-1887-6 · Cited by 5
“Currently 38% of adults in the USA have prediabetes [2], which is associated with an approximately threefold greater annual incidence of T2DM [3] and an approximately 50% greater risk of cardiovascular disease [4–6].”
Background
Metadata
- Authors
- Zhang, X., Gregg, E. W., Williamson, D. F., Barker, L. E., Thomas, W., Bullard, K. M., Imperatore, G., Williams, D. E., & Albright, A. L.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Emory University (US)
- Corresponding author
- Zhang, Xuanping
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-07-01
- Volume
- 33
- Issue
- 7
- Pages
- 1665-1673
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890379
- OpenAlex
- W2137837290
- Cited by
- 422
- References
- 32
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 30 · 2023: 34 · 2022: 28 · 2021: 34 · 2020: 22 · 2019: 22 · 2018: 22 · 2017: 27 · 2016: 27 · 2015: 29 · 2014: 26 · 2013: 29 · 2012: 24
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- HbA1c, new-onset diabetes, diabetes risk prediction, prediabetes, diabetes prevention, HbA1c thresholds, diabetes incidence
- MeSH terms
- Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Risk Factors, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

